# 1. Financial Performance ## A. Key Figures * **Revenue from Operations:** **₹255 Cr** Q2 FY26 (+2%) · **₹509 Cr** H1 FY26 (+37%) * EBITDA: ₹55.3 Cr H1 FY26 (+50.6%) · ₹26.2 Cr Q2 FY26 (+37.5%) * PAT: ₹39.2 Cr H1 FY26 (+49.7%) · ₹18.2 Cr Q2 FY26 (+36.7%) * **Gross Profit:** **₹84.6 Cr** Q2 FY26 (+25%) * PBT: **₹21.9 Cr** Q2 FY26 (+37.5%) ## B. Profit Margins * **Margin Pressure in Q2:** EBITDA margin declined to **3%** from **4%** in Q1 despite operational efficiency and favorable product mix, due to timing-driven expense concentration in Q2. * **Gross Margin Resilience:** Gross margin held stable at **2%** amid strong 25% YoY gross profit growth, indicating pricing power and cost control. * **Management Margin Outlook:** EBITDA margin expected to trend toward **10%** over time on improving industry demand-supply dynamics; current run rate estimated at **5–8%**. ## C. Balance Sheet * **Strong Liquidity Position:** Holds **₹162 Cr** in non-lein deposits as of Sep-25, enabling self-funded expansion with no reliance on external debt. ## D. Cash Flow * **Healthy Cash Management:** Company maintains surplus cash, positive interest income, and disciplined control over working capital, inventory, and debt. * **Operational Execution:** Sustained financial performance underpinned by efficiency and execution discipline, with cash deployed as working capital margin. --- # 2. Segment & Product Performance ## A. Key Figures * **Fertilisers Revenue:** **₹124 Cr** (+6% YoY, -9% QoQ) * **Fertilisers Volume:** **72,526 MT** (+2% YoY, -9% QoQ) * **Chemicals Revenue:** **₹132 Cr** (+40% YoY, +11.8% QoQ) * **Chemicals Volume:** **17,266 MT** (+3% YoY, +4% QoQ) * **Utilization Rates:** **70%** Fertilisers · **65%** Chemicals ## B. Fertilisers Segment * **Resilient Growth:** Fertilisers revenue and volume rose YoY on strong agricultural demand, despite seasonal QoQ softness. * **Strategic Expansion:** ₹350 Cr capex allocated to fertilisers; Unit 5 commissioning underway, reinforcing long-term commitment to the segment. * **Product Differentiation:** Focus on water-soluble and NPK fertilizers insulates business from urea supply shocks and supports premium positioning. ## C. Chemicals Segment * **Strong Momentum:** Chemicals segment delivered robust revenue growth and volume recovery, driven by improved realizations and end-market demand. * **Operational Upside:** Volumes up over **10% QoQ** and ~20% in H1 FY26 vs. prior year, signaling turnaround and operational improvement. * **Sustainability in Focus:** Analysts probing durability of performance; management acknowledges inherent volatility but highlights positive trends. ## D. Dyes & Intermediates * **Structural Enhancement:** Launch of wholly-owned marketing subsidiary **Dyecol Color Technologies** to boost market reach and strategic focus in dyes business. * **Export Exposure:** Dye stuff sales primarily export-oriented, creating vulnerability to global trade shifts and currency fluctuations. --- # 3. Capacity & Expansion ## A. Key Figures * Solar Capacity: **9.0 MW DC** current · **10 MW DC** Shree Pushkar + **1.10 MW DC** Kisan Phosphates * **Capex Commitments:** **₹110 Cr** for Unit 6 · **₹350 Cr** for Unit 8 ## B. Unit 5 & Unit 6 * **Execution Delays:** Timeline setbacks due to **prolonged monsoon** and **inadequate grid power**, with trial operations contingent on transformer installation by **February 2026**. * **Power Dependency:** Full-load operations require **3 MW grid connection**; diesel generators cannot support trial runs, creating critical path risk. * **Production Outlook:** Unit 6 output could range from **9 to 12 months** of full operation depending on electricity availability, with **1–5 months of stabilization** post-trials. * **Backward Integration:** Unit 5 to host **new acid production capacity**, while Unit 6’s smaller acid plant leverages two existing facilities; both support **100% in-house phosphoric acid** goal. ## C. Unit 8 Project * **Expansion on Track:** Unit 8 aims for **March 2028** commissioning, with **5-month execution timeline** expected based on prior experience. * **Cost Optimization Focus:** Project to reduce electricity costs via **10 MW DC solar integration**, enhancing margins without increasing sales volume. ## D. Solar Capacity * **Renewables Buildout:** Current solar capacity at **0 MW DC**, with **6 MW DC underway** and **20 MW DC** in development across Shree Pushkar and Kisan Phosphates. * **Strategic Self-Reliance:** Solar investments target improved energy security and lower emissions, though no formal renewable penetration target disclosed. --- # 4. Capital Allocation ## A. Key Figures * Capex (Multiple Projects): ₹350 Cr for Meghnagar, MP expansion; Unit 8 NPK capex not specified * Funding Deployed: **close to ₹400 Cr** deployed toward capex; **₹30 Cr** promoter preferential allotment planned (MP expansion) ## B. Capex Plan * **Strategic Expansion:** Three major Greenfield projects underway—Meghnagar, MP, and Unit 8 NPK—each involving significant scale and **backward integration**, with full commissioning targeted by **FY28**. * **Non-Linear Scaling:** Capex per ton not proportional to prior projects due to **enhanced design efficiency** and expanded scope, refuting assumptions of lower spend for smaller capacity. * **Project Integration & Sustainability:** New facilities emphasize **full integration** (e.g., sulfuric acid production) and **renewable energy adoption**, enhancing long-term cost control and ESG alignment. ## C. Funding Sources * **Self-Sustained Funding Model:** Capex historically and prospectively financed primarily through **internal accruals**, minimizing debt and ensuring financial flexibility. * **Promoter Confidence:** Select **preferential allotments** reinforce promoter commitment and provide targeted capital without broad equity dilution. --- # 5. Demand & Pricing Trends ## A. Key Figures * **Revenue (New Facility):** **₹1,200 Cr** conservative estimate · **₹1,500–1,600 Cr** theoretical max at full capacity ## B. Agricultural Demand * **Capacity-Led Growth:** New facility poised to materially expand revenue base, with significant headroom for output scaling under practical and full-capacity scenarios. --- # 6. Risks & External Factors ## A. Operational Disruptions & External Dependencies * **Critical Power Infrastructure Delay:** Installation of a **new transformer**—essential for operations—is delayed, with completion now expected by **February 2026**, pending action by external agencies despite escalation via the **MAITRI portal**. * **Unit 5 Ramp-Up Contingent on Power:** Commercial operation of **Unit 5** will only commence post-February, dependent on securing **additional electricity load allocation**. * **Weather and Input Shocks Weighed on Q2:** **Haryana-Punjab floods** disrupted operations in Q2, undercutting performance despite strong SST sales momentum; earlier **fertilizer and urea shortages** also pressured the agri-sector, though government intervention has stabilized supply. ## B. Geopolitical and Trade Headwinds * **Tariff Pressures in Textiles:** U.S. tariffs are acknowledged to have caused **direct and indirect impacts** on textile players, with effects varying by business model—company views overall exposure as limited. * **Chemical Segment Faces Macro Headwinds:** Despite current volume growth, the chemical business faces **downside risks** from geopolitical tensions and demand-supply imbalances; firm emphasizes proactive risk mitigation on uncontrollable external factors. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Guidance (FY26):** **₹950 Cr** (official) · **₹1,000 Cr** (updated visibility) * **PAT Margin (FY26):** **8%** targeted * **Long-Term Revenue (FY29):** **₹2,500–3,000 Cr** potential · **₹2,500 Cr** conservative case ## B. Revenue Targets * **Raised FY26 Visibility:** Management sees clear line of sight to **₹1,000 Cr** revenue in FY26, up from prior **₹950 Cr** guidance, supported by strong H1 performance of **₹510 Cr**. * **Multi-Year Scaling Path:** Combined ramp-up of Units 5, 6, and 8 underpins **multi-billion-rupee growth trajectory**, with **FY29 revenue potential** reaching **₹3,000 Cr** in base case. * **Execution Risks Acknowledged:** Outlook includes buffer for **2–3 month delays** due to external factors, reinforcing conservative stance despite upside momentum. ## C. Margin Expectations * **Near-Term Margin Pressure:** FY26 EBITDA margin expected at **~8%**, below long-term band, due to near-term performance dynamics in **Q3 and Q4**. * **Structural Discipline Intact:** Long-term **11%–12% EBITDA margin** target remains unchanged, reflecting commitment to financial rigor and operational efficiency. * **Business Resilience:** Chemicals segment seen as **well-positioned with ongoing opportunities**, providing stable foundation for margin recovery.